Heart Disease Trial, Recruiting NCT04071015 Sponsor: Biobeat Technologies Ltd. Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT04071015
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 and over, of any sex, who are admitted to the intensive care unit directly after heart surgery and require blood pressure monitoring through an arterial line (a thin tube placed in the wrist or groin artery) or a Swan-Ganz catheter (a tube placed in the heart to monitor circulation).

Who may not be able to join:

  • People who do not wish to participate in the trial.
  • People for whom an arterial line is not needed or cannot be safely placed.
  • Women who are pregnant.
  • People under the age of 18.
  • People with a mental illness or condition that affects their ability to make decisions about participation (confirm with trial site).
  • People who work at Sheba Medical Center.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erez Kachel, MD, The Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Phone: +972-52-9210896

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Biobeat Technologies Ltd.
Registry
ClinicalTrials.gov
Start date
15 June 2020
Est. completion
1 November 2026

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Level of accordance between the Biobeat monitor and the arterial line

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov